FR2226173A1 - 1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides - Google Patents

1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides

Info

Publication number
FR2226173A1
FR2226173A1 FR7411521A FR7411521A FR2226173A1 FR 2226173 A1 FR2226173 A1 FR 2226173A1 FR 7411521 A FR7411521 A FR 7411521A FR 7411521 A FR7411521 A FR 7411521A FR 2226173 A1 FR2226173 A1 FR 2226173A1
Authority
FR
France
Prior art keywords
alkyl
epoxides
napthoxy
arrhythmics
cyclopropa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7411521A
Other languages
French (fr)
Other versions
FR2226173B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2226173A1 publication Critical patent/FR2226173A1/en
Application granted granted Critical
Publication of FR2226173B1 publication Critical patent/FR2226173B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/121,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Abstract

Cpds of formula (I): (where R1 and R2 are H, alkyl or alkoxy; R3 is H, Cl, Br, alkyl, carbalkoxy or CH2OH; R4 is H, Cl or Br; R5=H, (cyclo)alkyl or alkoxy and R6 and R7 are H, alkyl, hydroxyalkyl, phenylalkyl or phenyl; or NR6R7 is a 5- or 6-membered ring opt. contg. O,S or N as a further hereto atom) and their acid addn salts are drugs suitable for the treatment of heart rhythm disorders. They may be obtd by reacting amines of the formula HNR6R7 with epoxides of formula (I; where -CH(OH)CH2NR6R7 is replaced by -CH-CH2).
FR7411521A 1973-04-18 1974-03-29 1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides Granted FR2226173A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35215573A 1973-04-18 1973-04-18

Publications (2)

Publication Number Publication Date
FR2226173A1 true FR2226173A1 (en) 1974-11-15
FR2226173B1 FR2226173B1 (en) 1977-07-01

Family

ID=23384012

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7411521A Granted FR2226173A1 (en) 1973-04-18 1974-03-29 1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides

Country Status (3)

Country Link
JP (1) JPS5018451A (en)
DE (1) DE2418776A1 (en)
FR (1) FR2226173A1 (en)

Also Published As

Publication number Publication date
FR2226173B1 (en) 1977-07-01
DE2418776A1 (en) 1974-10-31
JPS5018451A (en) 1975-02-26

Similar Documents

Publication Publication Date Title
ES436316A1 (en) 1-Aryloxy-2-hydroxy-3-alkynylamino-propanes
GB1369248A (en) Amides the preparation thereof and their use in pharmacjeutical compositions
CH572905A5 (en) Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity
ES420643A1 (en) 13-Sulfa-prostaglandins
FR2226173A1 (en) 1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides
DK217983D0 (en) (-) - 15-DEOXYSPERGUALIN, ITS PRODUCTION AND USE
ES413153A1 (en) Pharmacologically active anilinobenzothiazoles
ES418857A1 (en) Sulfur-containing ring compounds
GB1292787A (en) Benzodioxane derivatives and pharmaceutical compositions containing them
FR2258840A1 (en) (4-Phenylpiperazino) alkyl esters - with analgesic activity for human and veterinary use
ES434827A1 (en) Azidophenol amine compounds and therapeutic compositions
FR2244514A1 (en) 1,2-Dihydroquinoline derivs - useful as anti-inflammatories
ES429328A1 (en) N-substituted glycinates
ES445969A1 (en) Substituted piperazine derivative, its preparation and anorexia compositions containing it
ES8306734A1 (en) Bis-aminomethyl-anthraquinone derivatives, process for their manufacture, compositions containing them and their use.
FR2171937A1 (en) Aminoketo indoles - analgesics and antidepressants
ES438537A1 (en) 1-(2,4,6-Trihydroxyphenyl)-propanedione-(1,2)-compounds and therapeutic compositions
FR2228779A1 (en) (4-Phenylpiperazino) alkyl esters - with analgesic activity for human and veterinary use
ES396175A1 (en) Phenylethanolamine derivatives
ES445543A1 (en) Morpholine compounds and methods of use
FR2139740A1 (en) 1-amino-3-methyl-3-phenoxy-2-butanols - inhibitors of platelet stickiness for treatment of thrombosis
FR2164520A2 (en) 2-(n-heterocyclic amino)thiazolin-4-ones - with respiratory analeptic activity
GB1037013A (en) Naphthylacetamide derivatives
FR2210388A1 (en) 4-Phenoxy-3-hydroxy-butyramidines - as agents for treating cardiac rhythm disorders
FR2068434A1 (en) Beta-amino-acrylophenone derivs

Legal Events

Date Code Title Description
ST Notification of lapse